These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1220236)

  • 21. [Effect of adrenaline on the ability of intact erythrocytes to increase the thromboplastin activity of plasma].
    Ashkinazi IIa
    Biull Eksp Biol Med; 1969; 67(1):3-5. PubMed ID: 5404401
    [No Abstract]   [Full Text] [Related]  

  • 22. [The effect of ethyl-chlorophenoxyisobutyrate on the serum lipids in coronary sclerosis].
    Keller L; Rétsági G; Sebestyén M; Diczendy S; Erdélyi G
    Z Gesamte Inn Med; 1966 Mar; 21(6):169-72. PubMed ID: 5988081
    [No Abstract]   [Full Text] [Related]  

  • 23. [Miscleron in the treatment of patients with atherosclerosis of the coronary and cerebal vessels].
    Sivkov II; Kukes VG; Kirichenko LL; Fedosova NS; Ishmaeva KA
    Sov Med; 1971 Sep; 34(9):54-7. PubMed ID: 5121295
    [No Abstract]   [Full Text] [Related]  

  • 24. [Changes of certain indicators of blood coagulation in patients with coronary arteriosclerosis and hypertensive disease].
    Pliutto AM
    Lab Delo; 1974; 8(0):465-8. PubMed ID: 4139365
    [No Abstract]   [Full Text] [Related]  

  • 25. [Cholesterol: how and when to treat it?].
    Masana Marín L
    Med Clin (Barc); 1985 Oct; 85(10):423-5. PubMed ID: 4079497
    [No Abstract]   [Full Text] [Related]  

  • 26. Modulation of coronary endothelial function by lovastatin.
    Misra A
    Natl Med J India; 1995; 8(6):271-2. PubMed ID: 8520448
    [No Abstract]   [Full Text] [Related]  

  • 27. [Further data on the use of a preparation with antisclerotic action in geriatrics].
    Solaro F; Zinnari A; Dinale M
    G Gerontol; 1970 Mar; 18(3):177-84. PubMed ID: 5473220
    [No Abstract]   [Full Text] [Related]  

  • 28. [The use of heparin and fibrinolysin in patients with coronary arteriosclerosis].
    Aleĭnikova LI
    Vrach Delo; 1966 Mar; 3():53-6. PubMed ID: 4230197
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of drug preparations used in treating coronary arteriosclerosis on the coagulogram and blood biochemical indices].
    Semavin IE; Goliakov VN; Semiletov VI; Solov'ev VV
    Sov Med; 1979 Jan; (1):31-5. PubMed ID: 424857
    [No Abstract]   [Full Text] [Related]  

  • 30. [Better clinical outcome in coronary disease patients with lower level of low-density lipoprotein cholesterol].
    Zhao SP
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(13):865-7. PubMed ID: 16029518
    [No Abstract]   [Full Text] [Related]  

  • 31. [Thrombodensitographic changes during treatment with a coumarin derivative].
    Ferri F; Regazzini A
    Minerva Med; 1970 Jan; 61(8):309-18. PubMed ID: 4189912
    [No Abstract]   [Full Text] [Related]  

  • 32. [Abnormal lipid metabolism and coronary insufficiency].
    Murakami M; Sekimoto H; Tanaka I; Seo M; Takegoshi T
    Saishin Igaku; 1970 Jan; 25(1):101-9. PubMed ID: 5450347
    [No Abstract]   [Full Text] [Related]  

  • 33. [Thrombelastogram in patients with coronary arteriosclerosis and auricular fibrillation].
    Tereshchenko OI
    Vrach Delo; 1974 Nov; 0(11):78-9. PubMed ID: 4432481
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of nerobol on indices of the coagulogram in patients with rheumatism and circulatory insufficiency of the 2B-3 stage].
    Furtel' VA
    Vrach Delo; 1977 Jun; (6):38-9. PubMed ID: 302065
    [No Abstract]   [Full Text] [Related]  

  • 35. [The effect of retabolyl on the lipid and protein metabolism of coronary atherosclerosis patients].
    Savenkov PM; Segal' RG
    Kardiologiia; 1969 Jul; 9(7):95-100. PubMed ID: 5372695
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of submaximal physical exertion on serum lipid levels and the blood coagulation and fibrinolysis systems in patients with arteriosclerosis].
    Markiewicz K; Cholewa M; Jazdzewski B; Gawor Z
    Pol Tyg Lek; 1984 Jun 12-25; 39(25-26):857-61. PubMed ID: 6494044
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of the antioxidant, ionol, on blood coagulation in ischemic heart disease].
    Shkliar AS
    Vrach Delo; 1980 Sep; (9):52-4. PubMed ID: 7423951
    [No Abstract]   [Full Text] [Related]  

  • 38. [Influence of beta-benzabutyramide on the blood lipids and on the thrombodensitogram].
    Ferri F; Regazzini A; Pedini G
    G Gerontol; 1970 Mar; 18(3):203-18. PubMed ID: 5473222
    [No Abstract]   [Full Text] [Related]  

  • 39. After the failure of ENHANCEd cholesterol lowering in familial hypercholesterolemia, SEAS of problems with ezetimibe.
    Mascitelli L; Ravnskov U; Pezzetta F; Goldstein MR
    Angiology; 2009; 60(1):127-8; author reply 129-30. PubMed ID: 19049996
    [No Abstract]   [Full Text] [Related]  

  • 40. [Increase of fibrinolytic activity and reduction of platelet adhesiveness caused by prolonged treatment with ethyl-chloro-phenoxy-isobutyrate].
    Frandoli G; Gibelli A; Giarola P
    Clin Ter; 1966 Jul; 38(1):27-38. PubMed ID: 4230052
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.